Partner and head of private M&A group in London, with a focus on pharmaceutical and healthcare companies. Recent transactions include: acting for Basilea Pharmaceuticals in connection with its licensing agreement with Pfizer for its antifungal product, Cresemba, for Europe, Russia and Turkey; acting for ICU Medical, Inc in connection with the acquisition of the Hospira infusion business from Pfizer.
Trained Clyde & Co; qualified 1992; Baker McKenzie 1994; partner 1999.
Born 1968; resides London. Educated at Queen Mary College, London (LLB); College of Law, Lancaster Gate. Languages: French, Spanish. Leisure includes badminton and hiking.